Salaera D.B.A Perma Pure FDA Inspection Record
Salaera D.B.A Perma Pure is an FDA-registered facility (FEI 2244684) located in Lakewood, NJ, US. RegDataLab tracks 7 FDA inspections and 1 compliance action at this facility.
What FDA found at this site
- Latest inspection
- Mar 6, 2026: No Action Indicated (NAI)
- Inspections on record
- 7 (2 OAI, 1 VAI, 4 NAI)
- Last OAI inspection
- Mar 18, 2011
- Warning letters
- 1 listed by FDA for this FEI, latest Sep 21, 2010
Inspections and what FDA cited
| Date | Result | What FDA cited |
|---|---|---|
| Mar 6, 2026 | No Action Indicated (NAI) | No citations listed |
| Jan 3, 2020 | No Action Indicated (NAI) | No citations listed |
| Jan 21, 2016 | No Action Indicated (NAI) | No citations listed |
| Jul 9, 2013 | No Action Indicated (NAI) | Training - Lack of or inadequate procedures (21 CFR 820.25(b)) Lack of or inadequate receiving acceptance procedures (21 CFR 820.80(b)) Complaints (21 CFR 820.198(a)) Nonconforming product, Lack of or inadequate procedures (21 CFR 820.90(a)) and 2 more |
| Sep 19, 2011 | Voluntary Action Indicated (VAI) | Contamination control, Lack of or inadequate procedures (21 CFR 820.70(e)) |
| Mar 18, 2011 | Official Action Indicated (OAI) | Lack of or inadequate complaint procedures (21 CFR 820.198(a)) DHR content (21 CFR 820.184) Documentation of software validation (21 CFR 820.70(i)) Process changes - review, evaluation and revalidation (21 CFR 820.75(c)) and 2 more |
| Aug 23, 2010 | Official Action Indicated (OAI) | Lack of or inadequate complaint procedures (21 CFR 820.198(a)) Documentation (21 CFR 820.80(e)) Lack of or inadequate procedures (21 CFR 820.100(a)) DHR content (21 CFR 820.184) and 8 more |
FDA record score
0 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.
4 records behind this number
| Record | Date | Points x age weight | Adds |
|---|---|---|---|
| Inspection classified VAI | Sep 19, 2011 | 10 years or older, so it adds no points | 0 |
| Inspection classified OAI | Mar 18, 2011 | 10 years or older, so it adds no points | 0 |
| Warning letter on FDA's dashboard, which does not show close-outs | Sep 21, 2010 | 10 years or older, so it adds no points | 0 |
| Inspection classified OAI | Aug 23, 2010 | 10 years or older, so it adds no points | 0 |
When each source was last refreshed
| Records | Last refreshed | Source as of | Status |
|---|---|---|---|
| Inspections | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Inspection citations | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions (warning letters, injunctions and other action types) | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
| Warning letter text | Nov 16, 2026 | Newest record Nov 10, 2026 | Current |
| Recalls (Enforcement Report) | Nov 16, 2026 | Newest record Nov 11, 2026 | Current |
| Form 483s and inspection documents | Nov 13, 2026 | Newest record Nov 12, 2026 | Current |
| Import refusals | Nov 15, 2026 | Newest record Nov 5, 2026 | Current |
Reviewing Salaera D.B.A Perma Pure as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Salaera D.B.A Perma Pure yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Facility details
- Company
- Perma Pure LLC
- Location
- Lakewood, NJ (US)
- Source
- device